Trials / Unknown
UnknownNCT02147444
Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation
Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Japanese Clinical Practice
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,000 (estimated)
- Sponsor
- Tohoku University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy and safety of a novel oral Xa inhibitor for stroke and systemic embolism, namely rivaroxaban, in non-valvular atrial fibrillation patients are evaluated in Japanese clinical practice.
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2016-06-01
- First posted
- 2014-05-26
- Last updated
- 2014-05-26
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02147444. Inclusion in this directory is not an endorsement.